Afuco™ Anti-Human MS4A1 ADCC Therapeutic Antibody (BLX-301), ADCC Enhanced

Anti-MS4A1 ADCC Enhanced Antibody (BLX-301) is an ADCC enhanced antibody produced by our Afuco™ platform. BLX-301 is a humanized and glyco-optimized anti-CD20 antibody for the treatment of non-Hodgkin's B-cell lymphoma and other B-cell malignancies.
Supplier Creative Biolabs
Product # AFC-515CL
Pricing Inquiry
Host Humanized
Target MS4A1
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at –20 or -70°C upon receipt. Divide antibody into aliquots prior usage and avoid multiple freeze-thaw cycles.
Feedback